Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status:
Completed
Trial end date:
2014-03-13
Target enrollment:
Participant gender:
Summary
The goal of the current trial is to obtain long term efficacy, safety and tolerability data
of once weekly aripiprazole in children and adolescents with Tourette's Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.